2025-2034 Disease Registry Software Market Evolution: Disruptions, Innovations, and Untapped Opportunities

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Disease Registry Software Market Through 2025?
In recent times, the disease registry software market has seen swift expansion. It's projected to increase from $1.39 billion in 2024 to $1.55 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.6%. This growth in the past can be linked to the escalating burden of chronic diseases, the surge in clinical research and trials, the growing incidence of rare diseases, quick adoption of electronic health records (EHRs), and an increasing rate of chronic diseases.

What's the Projected Size of the Global Disease Registry Software Market by 2029?
The market size for disease registry software is anticipated to experience swift expansion in the forthcoming years, reaching $2.38 billion in 2029 and witnessing a compound annual growth rate (CAGR) of 11.2%. This anticipated surge in the prediction period can be credited to the increasing implementation of value-based care models, escalating utilization of real-world evidence (RWE), development of precision medicine initiatives, ascend in chronic and lifestyle diseases, along with a growing emphasis on patient-focused healthcare. Key trends expected within the forecast timeframe comprise progresses in healthcare Information technology (IT) structure, assimilation with telehealth and remote tracking, fusion with internet of things (IoT) and wearable devices, sophisticated data visualization and control panels, and the adoption of blockchain for ensuring data security and compatibility.

View the full report here:
https://www.thebusinessresearchcompany.com/report/disease-registry-software-global-market-report

Top Growth Drivers in the Disease Registry Software Industry: What's Accelerating the Market?
The expansion of the disease registry software market is anticipated to be driven by the rise in the application of personalized medicine. This approach in medicine pertains to the creation of prevention and treatment strategies, specifically suited to an individual's genetic composition, lifestyle, and environmental conditions. The growth in the utilization of personalized medicine can be primarily attributed to genomics advancements, allowing for the exact identification of genetic differences, and the formation of bespoke treatments for people. Disease registry software contributes to personalized medicine by methodically compiling and handling patient health data, which paves the way for customized treatment courses and improved medical decision making. This software simplifies the process of data access and assessment, increasing patient results and advancing precision healthcare. To illustrate, in February 2024 the U.S. Food and Drug Administration (FDA) sanctioned 26 novel personalized medicines in 2023 as stated by the Personalized Medicine Coalition (PMC), a non-profit organization based in the U.S. This is a substantial rise from the 12 sanctioned in 2022. Consequently, the growing use of personalized medicine is pushing the development of the disease registry software market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28208&type=smp

What Trends Will Shape the Disease Registry Software Market Through 2029 and Beyond?
The primary businesses in the disease registry software market are concentrating on producing registries centered around patients, like digital registries that monitor outcomes and facilitate personalized care. Digital registries are essentially electronic systems or software platforms that systematically gather, store, and control patient health data, outdating the formerly used paper-based registries. For instance, the American College of Cardiology (ACC), a US-based nonprofit medical association, commenced the CONNECT-HCM Registry in August 2025. This registry, functioning on a national level, aims to enhance the comprehension and management of hypertrophic cardiomyopathy (HCM), the most prevalent genetic cardiovascular disease. The registry paves the way for direct patient registrations beyond sole centers, countering ongoing diagnostic and care voids. This platform integrates registry information with electronic health records by way of Arboretum's Hugo Connect platform, and it assists researchers in tracking symptoms, imaging, treatments, and outcomes over time.

What Are the Main Segments in the Disease Registry Software Market?
The disease registry software market covered in this report is segmented as

1) By Type: Standalone, Integrated
2) By Database: Public, Commercial
3) By Deployment Mode: On-Premises, Cloud-Based
4) By End-User: Hospitals, Government Organizations, Research Centers, Pharmaceutical Companies, Other End Users

Subsegments:
1) By Standalone: Patient Registry Software, Population Health Registry Software, Research Registry Software, Custom Or Single-Disease Registry Software
2) By Integrated: Electronic Health Record (EHR)-Integrated Registry Software, Practice Management System-Integrated Registry Software, Clinical Decision Support (CDS)-Integrated Registry Software, Health Information Exchange (HIE)-Integrated Registry Software

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28208&type=smp

Which Top Companies are Driving Growth in the Disease Registry Software Market?
Major companies operating in the disease registry software market are Optum Inc., IQVIA Holdings Inc., Syneos Health Inc., Epic Systems Corporation, Premier Inc., MRO Corp., ImageTrend Inc., Anju Software Inc., BayaTree Inc., Medrio Inc., ArborMetrix Inc., Cedaron Medical Inc., Evado Pty. Ltd., OpenClinica LLC, Dacima Software Inc., Global Vision Technologies Inc., Ordinal Data Inc., Healthmonix LLC, Axis Clinical Software Inc., and Vanderbilt University.

Which Regions Will Dominate the Disease Registry Software Market Through 2029?
North America was the largest region in the disease registry software market in 2024. The regions covered in disease registry software report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28208

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.